EZH2 and breast cancer: High expression of lncRNA H19 was identified as a powerful factor associated with paclitaxel resistance in ERα-positive BC cells through epigenetic silencing of the pro-apoptotic gene BIK, through the recruitment of EZH2 and trimethylation of histone H3 to lysine 27 [254].